Missed opportunities for Hepatitis B vaccination among diabetic patients

References

• Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA. Immunosenescence: Implications for vaccination programmes in adults. Maturitas 2011; 68:322-30; PMID:21316879; http://dx.doi.org/10.1016/j.maturitas.2011.01.011
   PubMed Web of Science ®Google Scholar
• Centers for Disease C, Prevention. Impact of vaccines universally recommended for children-United States, 1990-1998. MMWR 1999; 48:243-8; PMID:10220251
   PubMedGoogle Scholar
• Centers for Disease C, Prevention. Recommended adult immunization schedule – United States, 2014. J Midwifery & Women's Health 2014; 59:205-9; PMID:24618112; http://dx.doi.org/10.1111/jmwh.12184
   PubMed Web of Science ®Google Scholar
• Erişkin aşılama önerileri. Turkish Society of Internal Medicine, 2009.
   Google Scholar
• Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Respir Crit Care Med 2005; 26:563-74; PMID:16388428; http://dx.doi.org/10.1055/s-2005-925523
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362:1733-45; PMID:14643124; http://dx.doi.org/10.1016/S0140-6736(03)14854-4
   PubMed Web of Science ®Google Scholar
• Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am 2007; 21:617-38, vii; PMID:17826615; http://dx.doi.org/10.1016/j.idc.2007.07.003
   PubMed Web of Science ®Google Scholar
• Schillie SF, Xing J, Murphy TV, Hu DJ. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999-2010. J Viral Hepatit 2012; 19:674-6; PMID:22863272; http://dx.doi.org/10.1111/j.1365-2893.2012.01616.x
   PubMed Web of Science ®Google Scholar
• Byrd KK HR, Mehal, J, Murphy TV Chronic liver disease-associated hospitalizations among adults with diabetes-United States, 2001-2008. Abstracts of the American Association for the study of liver diseases 62nd annual meeting. November 4–8, 2011. San Francisco, California, USA. Hepatology 2011; 54 Suppl:360A-1513A.
   Google Scholar
• Reilly ML, Schillie SF, Smith E, Poissant T, Vonderwahl CW, Gerard K, Baumgartner J, Mercedes L, Sweet K, Muleta D, et al. Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus. J Diabetes Sci Technol 2012; 6:858-66; PMID:22920812; http://dx.doi.org/10.1177/193229681200600417
   PubMedGoogle Scholar
• Centers for Disease C, Prevention. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and mortality weekly report 2011; 60:1709-11; PMID:22189894
   PubMedGoogle Scholar
• Kirkman MS, Schaffner W. Another shot to protect people with diabetes: add hepatitis B vaccination to the checklist. Diabetes Care 2012; 35:941-2; PMID:22517936; http://dx.doi.org/10.2337/dc12-0164
   PubMed Web of Science ®Google Scholar
• Satman I. TURDEP II sonuçlarının özeti. 2011.
   Google Scholar
• Toy M, Onder FO, Wormann T, Bozdayi AM, Schalm SW, Borsboom GJ, van Rosmalen J, Richardus JH, Yurdaydin C. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC infectious diseases 2011; 11:337; PMID:22151620; http://dx.doi.org/10.1186/1471-2334-11-337
   PubMed Web of Science ®Google Scholar
• Akarca US. Chronic hepatitis B. A guideline to diagnosis, approach, management, and follow-up 2007. Turk J Gastroenterol 2008; 19:207-30
   PubMed Web of Science ®Google Scholar
• Hope VD, Eramova I, Capurro D, Donoghoe MC. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiology and infection 2014; 142:270-86; PMID:23714072; http://dx.doi.org/10.1017/S0950268813000940
   PubMed Web of Science ®Google Scholar
• Kanra G, Tezcan S, Badur S, Turkish National Study T. Hepatitis B and measles seroprevalence among Turkish children. The Turkish journal of pediatrics 2005; 47:105-10; PMID:16052847
   PubMed Web of Science ®Google Scholar
• Tosun S. Viral hepatitlerin ülkemizdeki değişen epidemiyolojisi. ANKEM Derg 2013; 27:128-34
   Google Scholar
• Demir M, Serin E, Gokturk S, Ozturk NA, Kulaksizoglu S, Ylmaz U. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients. Eur J Gastroenterol Hepatol 2008; 20:668-73; PMID:18679070; http://dx.doi.org/10.1097/MEG.0b013e3282f55e1e
   PubMed Web of Science ®Google Scholar
• Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1:550-1; PMID:6111645; http://dx.doi.org/10.1016/S0140-6736(81)92877-4
   PubMed Web of Science ®Google Scholar
• Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992; 15:256-60; PMID:1547682; http://dx.doi.org/10.2337/diacare.15.2.256
   PubMed Web of Science ®Google Scholar
• Pozzilli PSA, Leslie RDG. Infections, immunity and diabetes. In: Pickup JWG, ed. Text book of diabetes: Oxford: Blackwell Science Ltd., 1997:1231-41.
   Google Scholar
• Byrd KK, Lu PJ, Murphy TV. Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination. Vaccine 2012; 30:3376-82; PMID:22472793; http://dx.doi.org/10.1016/j.vaccine.2012.03.055
   PubMed Web of Science ®Google Scholar
• Esparza-Martin N, Hernandez-Betancor A, Suria-Gonzalez S, Batista-Garcia F, Braillard-Pocard P, Sanchez-Santana AY, Guerra-Rodriguez R, Ramirez-Puga A, Checa-Andres MD. Serology for hepatitis B and C, HIV and syphilis in the initial evaluation of diabetes patients referred for an external nephrology consultation. Nefrologia 2013; 33:124-7; PMID:23364635
   PubMed Web of Science ®Google Scholar
• Hurley LP, Bridges CB, Harpaz R, Allison MA, O'Leary ST, Crane LA, Brtnikova M, Stokley S, Beaty BL, Jimenez-Zambrano A, et al. U.S. physicians' perspective of adult vaccine delivery. Ann Intern Med 2014; 160:161; PMID:24658693; http://dx.doi.org/10.7326/M13-2332
   PubMed Web of Science ®Google Scholar
• Yi S, Nonaka D, Nomoto M, Kobayashi J, Mizoue T. Predictors of the uptake of A (H1N1) influenza vaccine: findings from a population-based longitudinal study in Tokyo. PLoS One 2011; 6:e18893; PMID:21556152; http://dx.doi.org/10.1371/journal.pone.0018893
   PubMed Web of Science ®Google Scholar
• Kanitz EE, Wu LA, Giambi C, Strikas RA, Levy-Bruhl D, Stefanoff P, Mereckiene J, Appelgren E, D'Ancona F. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine 2012; 30:5222-8; PMID:22721901; http://dx.doi.org/10.1016/j.vaccine.2012.06.012
   PubMed Web of Science ®Google Scholar
• Willis BC, Ndiaye SM, Hopkins DP, Shefer A. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged. MMWR Recomm Rep 2005; 54:1-11; PMID:15800472
   PubMedGoogle Scholar
• Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes. Diabetes Care 2013; 36:63-9; PMID:22933435; http://dx.doi.org/10.2337/dc12-0759
   PubMed Web of Science ®Google Scholar
• Tosun SAM, İsbir B. Hepatit B Virus infeksiyonu ile savaşımda ülke kaynaklarının ekonomik kullanımı. Viral Hepatit Dergisi 2007; 12:137-41
   Google Scholar